Better U Review: At-Home Ketamine From $76 a Session - the FDA-Approved Version Requires Two Hours of Monitoring

This is the comparison that should drive the decision, and it is a matter of public record rather than opinion. The FDA has approved one ketamine-derived medicine for depression: esketamine, marketed as Spravato, a nasal spray, for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behaviour. And the conditions the FDA attached to that approval are the point. Spravato is available only under a Risk Evaluation and Mitigation Strategy — a REMS — which requires that it be administered in a certified healthcare setting, under the direct observation of a healthcare provider, with the patient monitored for at least two hours afterwards. Patients cannot take it home. It cannot be dispensed to a pharmacy for self-administration. The FDA imposed those requirements because of the risks of sedation, dissociation, blood pressure elevation, and the potential for abuse and misuse. Generic ketamine used for depression is prescribed off-label. Off-label prescribing is legal, common and often appropriate — roughly a fifth of US prescriptions are off-label — and it is how many effective treatments reach patients. It also means the specific formulation, dose, route and setting have not been reviewed and approved for that use. Compounded oral ketamine, of the kind shipped for home use, is not an FDA-approved drug product. The FDA has issued a specific warning about compounded ketamine products for at-home treatment of psychiatric disorders, citing risks including sedation, dissociation, abuse and misuse, and — centrally — the absence of monitoring by a healthcare provider. So the honest framing is this. The evidence that ketamine has rapid antidepressant effects is genuine and taken seriously by the field; the American Psychiatric Association has acknowledged that. What is unresolved is whether an at-home, unmonitored, orally-dosed model delivers that benefit at an acceptable level of risk — and the regulator's own answer for the approved product was to require two hours of in-person observation. Two further points on the evidence: Oral ketamine has lower and more variable bioavailability than intravenous or intranasal routes. The dosing is less predictable, and most of the strongest antidepressant trial data comes from intravenous or intranasal administration rather than oral lozenges. Antidepressant effects of a single ketamine dose are typically short-lived — days to a couple of weeks — which is why programmes are sold in courses. That is a legitimate clinical rationale and it also explains why the commercial model is a multi-session package. None of this means the company is doing something improper. It means you should go in understanding that you are buying an off-label, compounded medicine, self-administered without professional monitoring, from a model the FDA has publicly flagged. That is a decision a well-informed adult can reasonably make with their clinician — but only if they know it.

Ketamine is a Schedule III controlled substance with real risks. These are the ones that matter for an at-home model. Acute effects during a session: Dissociation — a sense of detachment from your body, surroundings or self. This is the intended experience in this context, and it can also be frightening. Sedation. You should not be alone, should not drive, and should not be responsible for anyone else. Increases in blood pressure and heart rate. This is why a blood pressure cuff is included, and it is a genuine reason for caution in anyone with cardiovascular disease. Nausea and vomiting. This is the one people underestimate: vomiting while sedated and lying down carries an aspiration risk. Follow the fasting and positioning instructions exactly, and make sure your support person knows what to do. Confusion, anxiety, or transient worsening of mood. Risks with repeated or prolonged use: Bladder and urinary tract damage. Ketamine-induced uropathy — cystitis, urinary frequency and urgency, pain, and in severe chronic cases irreversible bladder damage — is a well-documented harm associated with repeated ketamine exposure. It is under-discussed in the wellness framing of this treatment. Report urinary urgency, frequency, pain on urination or blood in urine to your prescriber immediately. Liver effects. Elevated liver enzymes have been reported with repeated ketamine use. Dependence, tolerance and misuse. Ketamine has genuine abuse potential, which is precisely why the approved product is not dispensed for home use. Escalating your own dose or using outside the prescribed schedule is the specific pattern to guard against, and having a supply at home is what makes it possible. Cognitive effects with heavy long-term use. Who should not do this — and this list is why the screening consultation matters more than any other part of the programme: Anyone with a history of psychosis or schizophrenia, or a family history that raises that concern. Uncontrolled high blood pressure or unstable cardiovascular disease, including recent heart attack, unstable angina or aneurysmal vascular disease. Increased intracranial pressure, or certain eye conditions with raised intraocular pressure. Pregnancy or breastfeeding. A history of substance use disorder, particularly involving ketamine or other dissociatives. Severe liver disease. Untreated obstructive sleep apnoea or significant respiratory compromise, given the sedation. Anyone who cannot arrange a sober, capable support person to be physically present for every session. And crucially: this is not an emergency treatment. If you are in crisis, having thoughts of harming yourself, or unable to keep yourself safe, an at-home programme is not the right pathway. Call or text 988 in the US, or go to an emergency department. Acute suicidality needs immediate, in-person care. Medication interactions to disclose in full: benzodiazepines, which may blunt ketamine's antidepressant effect; opioids; other sedatives; alcohol; stimulants; monoamine oxidase inhibitors; and any blood pressure medication. Bring your complete medication list, including supplements, to the consultation.

If, having read the above, you and a clinician think this is appropriate, these are the things that separate a well-run service from a poorly-run one. Questions to ask before paying: Who is the prescribing clinician, what is their licence and is it current in my state? You are entitled to know the name and licence number. Verify it on your state licensing board's public database — it takes two minutes and it is the single most useful check you can make. How long is the initial consultation, and does the clinician review my full medical and psychiatric history, medications and substance use history? A brief intake for a controlled substance is a red flag. What happens if I am screened out? Is the consultation refundable, and is there any charge? Who monitors me during a session? The company describes peer support being present. Establish exactly what that person is expected to do, what training they need, and what the escalation route is if something goes wrong. What is the clinician's availability between sessions, and what is the after-hours route if I have an adverse reaction? What is the refund policy if I stop partway through a package? This is the most important commercial question, because you are prepaying for a course of a treatment that may not suit you. Get it in writing before purchasing. How is my dose determined and adjusted, and who reviews the response? Is talk therapy included, separate, or optional? The evidence for psychedelic-assisted approaches generally involves therapeutic support, not just the drug. How is the medication compounded, by which pharmacy, and is that pharmacy licensed in my state? On the financing, which deserves scrutiny. "Guaranteed Approval Financing" is a phrase to slow down over. Financing that approves everyone typically prices risk into the terms. Before signing: establish the APR, the total amount repayable, the term, any origination or administration fee, what happens if you stop treatment partway, and whether the obligation survives if you discontinue. Compare against a credit union personal loan or a 0% credit card offer, which are frequently cheaper. Financing a mental health treatment is not unreasonable — going into a high-cost agreement without knowing the APR is. On the marketing language, a few things to read carefully: "Clinicians trained at institutions such as Stanford, Harvard, and Johns Hopkins" describes where people trained, not an endorsement by those institutions. It is a legitimate credential statement and it is not an institutional imprimatur. "Evidence-based remote sessions" — the evidence base for ketamine in depression is real; the evidence base specifically for unmonitored at-home oral dosing is much thinner. Those are different claims. "Reform psychiatry from the diagnose and treat illness model to a thought expansion, neurological reset and spiritual health model" is a philosophical position rather than a clinical one. You are entitled to hold it; just be clear it is not a scientific claim. Testimonials. The site does carry appropriate disclaimers that individual results vary. Weight testimonials at zero regardless. What genuine alternatives exist, since anyone considering this has usually tried something already: there are several evidence-based options for treatment-resistant depression, including augmentation strategies, switching antidepressant class, esketamine in a certified clinic — which insurance often covers — transcranial magnetic stimulation, and electroconvulsive therapy for severe cases. Structured psychotherapy in adequate dose is also frequently under-delivered before people conclude therapy "did not work." Ask a psychiatrist what has not yet been tried, and specifically ask whether you would qualify for clinic-based esketamine under insurance — because that is the monitored, approved, often-covered version of the same idea.

What does Better U cost? Verified August 12, 2026: 5 sessions $500 ($100 each), 9 sessions $792 ($88 each), 15 sessions $1,350 ($90 each) and 27 sessions $2,076 ($76 each). Split-pay financing is offered from $45 to $82 a month. Not covered by insurance. Is ketamine FDA-approved for depression? Generic ketamine is not. Esketamine (Spravato), a nasal spray, is approved for treatment-resistant depression — and only under a REMS requiring administration in a certified healthcare setting with at least two hours of provider monitoring. It cannot be taken home. Has the FDA said anything about at-home ketamine? Yes. It has warned about compounded ketamine products for at-home treatment of psychiatric disorders, citing sedation, dissociation, abuse and misuse, and the absence of monitoring by a healthcare provider. Is it legal? Ketamine is a Schedule III controlled substance that may be prescribed off-label by a licensed clinician. Off-label prescribing is legal and common. That is different from being FDA-approved for this use. Do I need someone with me? Yes. The company requires peer support present during a session, and you should never take a dose alone. Establish in advance what that person is expected to do and what the escalation route is. What are the main risks? Acutely: dissociation, sedation, raised blood pressure and heart rate, nausea and vomiting with an aspiration risk if sedated. With repeated use: bladder and urinary tract damage, liver enzyme elevation, dependence and misuse. Who should not use it? Anyone with a history of psychosis or schizophrenia, uncontrolled hypertension or unstable cardiovascular disease, raised intracranial pressure, substance use disorder history, severe liver disease, or who is pregnant or breastfeeding. Is oral ketamine as effective as IV? Oral bioavailability is lower and more variable, and most of the strongest antidepressant trial data comes from intravenous or intranasal routes rather than lozenges. Does insurance cover it? The company states it does not. Clinic-based esketamine often is covered — ask a psychiatrist whether you would qualify. What should I ask before paying? The prescriber's name and state licence number, which you can verify on your state board's public database; the refund policy if you stop partway; the after-hours route for adverse reactions; and the APR and total repayable on any financing. Is this an emergency treatment? No. If you are in crisis or having thoughts of harming yourself, call or text 988 in the US, or go to an emergency department.